CD79A and nasopharyngeal carcinoma: Blood and NP brush tissue-sampling methods, which are less invasive than biopsies, show promise for diagnosing and monitoring NPC through detection of EBV-related biomarkers (such as VCA-IgA titer and EBV DNA load).